Gilead Sciences Stock Plummets
This is a news story, published by markets.businessinsider.com, that relates primarily to The Wall Street Journal news.
disease research news
For more disease research news, you can click here:
more disease research newsmarkets.businessinsider.com news
For more news from markets.businessinsider.com, you can click here:
more news from markets.businessinsider.comAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
Other biopharma firms. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Gilead news, biopharmaceutical company news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Gilead Sciencesmarkets.businessinsider.com
•Health
Health
Stock of the Day: Gilead Sciences falls on report the Trump administration could slash funds for HIV prevention
72% Informative
Federal funding for HIV prevention could be slashed, according to The Wall Street Journal .
Gilead Sciences fell 2.52% in premarket trading, falling to $ 107.45 per share.
The biopharmaceutical company is up 19.34% for the year .
The company makes medication for treating HIV and AIDS, including treatments for adults with HIV.
VR Score
67
Informative language
62
Neutral language
82
Article tone
formal
Language
English
Language complexity
45
Offensive language
likely offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links
Small business owner?